PL3150222T3 - Stabilne immunogenne kompozycje antygenów staphylococcus aureus - Google Patents

Stabilne immunogenne kompozycje antygenów staphylococcus aureus

Info

Publication number
PL3150222T3
PL3150222T3 PL16193095T PL16193095T PL3150222T3 PL 3150222 T3 PL3150222 T3 PL 3150222T3 PL 16193095 T PL16193095 T PL 16193095T PL 16193095 T PL16193095 T PL 16193095T PL 3150222 T3 PL3150222 T3 PL 3150222T3
Authority
PL
Poland
Prior art keywords
staphylococcus aureus
immunogenic compositions
aureus antigens
stable immunogenic
stable
Prior art date
Application number
PL16193095T
Other languages
English (en)
Polish (pl)
Inventor
Lakshmi Khandke
Akihisa NONOYAMA
Tamara Shafer HODGE
Sandeep Nema
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of PL3150222T3 publication Critical patent/PL3150222T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
PL16193095T 2010-12-22 2011-12-21 Stabilne immunogenne kompozycje antygenów staphylococcus aureus PL3150222T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201061426476P 2010-12-22 2010-12-22
EP16193095.3A EP3150222B1 (en) 2010-12-22 2011-12-21 Stable immunogenic compositions of staphylococcus aureus antigens
EP11804822.2A EP2654784B1 (en) 2010-12-22 2011-12-21 Stable immunogenic compositions of staphylococcus aureus antigens
PCT/IB2011/055883 WO2012085872A2 (en) 2010-12-22 2011-12-21 Stable immunogenic compositions of staphylococcus aureus antigens

Publications (1)

Publication Number Publication Date
PL3150222T3 true PL3150222T3 (pl) 2020-05-18

Family

ID=45444677

Family Applications (2)

Application Number Title Priority Date Filing Date
PL16193095T PL3150222T3 (pl) 2010-12-22 2011-12-21 Stabilne immunogenne kompozycje antygenów staphylococcus aureus
PL11804822T PL2654784T3 (pl) 2010-12-22 2011-12-21 Stabilne immunogenne kompozycje antygenów staphylococcus aureus

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL11804822T PL2654784T3 (pl) 2010-12-22 2011-12-21 Stabilne immunogenne kompozycje antygenów staphylococcus aureus

Country Status (18)

Country Link
US (1) US20130259896A1 (enExample)
EP (2) EP3150222B1 (enExample)
JP (1) JP6097478B2 (enExample)
KR (2) KR101808398B1 (enExample)
CN (1) CN103826656B (enExample)
AU (1) AU2011346535B2 (enExample)
BR (1) BR112013016153A2 (enExample)
CA (1) CA2819120C (enExample)
DK (2) DK3150222T3 (enExample)
ES (2) ES2614815T3 (enExample)
HU (2) HUE033072T2 (enExample)
IL (1) IL226793B (enExample)
MX (1) MX350170B (enExample)
PL (2) PL3150222T3 (enExample)
PT (2) PT2654784T (enExample)
RU (1) RU2570730C2 (enExample)
SI (2) SI3150222T1 (enExample)
WO (1) WO2012085872A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1793849A2 (en) 2004-09-22 2007-06-13 GlaxoSmithKline Biologicals SA Immunogenic composition for use in vaccination against staphylococcei
SA114350400B1 (ar) 2009-06-22 2016-05-26 ويث ال ال سي تركيبات وطرق لتحضير تركيبات مولدة للمناعة لمقترن بولي سكاريد كبسولي للنمط المصلي 5 و 8 من المكورات العنقودية الذهبية
CN107096020A (zh) 2009-06-22 2017-08-29 惠氏有限责任公司 金黄色葡萄球菌抗原的免疫原性组合物
EP2575870B1 (en) * 2010-06-04 2016-12-07 Wyeth LLC Vaccine formulations
AU2012266880A1 (en) * 2011-03-16 2013-10-03 Regents Of The University Of Minnesota Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus
GB201310008D0 (en) * 2013-06-05 2013-07-17 Glaxosmithkline Biolog Sa Immunogenic composition for use in therapy
EA201690859A1 (ru) * 2013-12-04 2016-11-30 Гликоваксин Аг Предотвращение инфекций, вызываемых staphylococcus aureus, гликопротеиновыми вакцинами, синтезированными в escherichia coli
IL310015B1 (en) * 2013-12-31 2025-10-01 Access To Advanced Health Inst Single vial formulation
WO2015155310A1 (en) * 2014-04-10 2015-10-15 Biotech Tools S.A. Hsp-free allergen preparation
WO2019036313A1 (en) * 2017-08-16 2019-02-21 Merck Sharp & Dohme Corp. CONJUGATED PNEUMOCOCCAL VACCINE FORMULATIONS
GB201802339D0 (en) 2018-02-13 2018-03-28 Glaxosmithkline Biologicals Sa Immunogenic composition
KR102646145B1 (ko) 2018-05-31 2024-03-11 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모공 축소용 조성물
WO2020027466A1 (ko) 2018-07-28 2020-02-06 주식회사 엑소코바이오 엑소좀의 동결건조 방법
KR102163806B1 (ko) 2018-07-30 2020-10-07 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물
CA3164420A1 (en) * 2020-01-13 2021-07-22 Jonathan Clapper Methods and compositions for preventing adsorption of therapeutic proteins to drug delivery system components

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4902506A (en) 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
JPS60500673A (ja) 1983-03-08 1985-05-09 コモンウエルス　セラム　ラボラトリ−ズ　コミツシヨン 抗原活性を有するアミノ酸配列
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
JPH0832638B2 (ja) 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
IT1253009B (it) 1991-12-31 1995-07-10 Sclavo Ricerca S R L Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6008341A (en) 1994-08-22 1999-12-28 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
WO1997014800A1 (en) 1995-10-16 1997-04-24 Smithkline Beecham Plc Novel saliva binding protein
GB9622159D0 (en) 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
GB9622660D0 (en) 1996-10-31 1997-01-08 Biocine Spa Immunogenic detoxified mutant toxin
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
WO1999027109A2 (en) 1997-11-26 1999-06-03 Inhibitex, Inc. EXTRACELLULAR MATRIX-BINDING PROTEINS FROM $i(STAPHYLOCOCCUS AUREUS)
US6680195B1 (en) 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
CA2777661C (en) * 1998-08-31 2014-10-21 Inhibitex, Inc. Multicomponent vaccines
US6936258B1 (en) 1999-03-19 2005-08-30 Nabi Biopharmaceuticals Staphylococcus antigen and vaccine
US7115730B1 (en) 1999-04-27 2006-10-03 Chiron Srl Immunogenic detoxified mutant E. coli LT-A-toxin
US7384640B1 (en) 1999-09-30 2008-06-10 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant
ATE249839T1 (de) 2000-06-08 2003-10-15 Intercell Biomedizinische Forschungs & Entwicklungs Gmbh Immunstimulierende oligodeoxynukleotide
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
MXPA03011133A (es) 2001-06-07 2004-12-06 Wyeth Corp Formas mutantes de holotoxina de colera como adyuvante.
IL159209A0 (en) 2001-06-07 2004-06-01 Wyeth Corp Mutant forms of cholera holotoxin as an adjuvant
CN100359327C (zh) 2001-06-15 2008-01-02 英希比泰克斯公司 识别凝血酶阴性的葡萄球菌和金黄色葡萄球菌的表面蛋白的交叉反应性单克隆抗体和多克隆抗体
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
US9296795B2 (en) 2003-03-07 2016-03-29 Wyeth Holdings, Llc. Polysaccharide-staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
US20060251675A1 (en) 2003-03-17 2006-11-09 Michael Hagen Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
GB0323103D0 (en) 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
EP1793849A2 (en) * 2004-09-22 2007-06-13 GlaxoSmithKline Biologicals SA Immunogenic composition for use in vaccination against staphylococcei
GB0606416D0 (en) * 2006-03-30 2006-05-10 Glaxosmithkline Biolog Sa Immunogenic composition
MX337528B (es) * 2006-03-30 2016-03-09 Glaxosmithkline Biolog Sa Composición inmunogénica que comprende un sacárido capsular estafilocócico o-acetilado y una proteína estafilocócica.
AR060188A1 (es) 2006-03-30 2008-05-28 Glaxosmithkline Biolog Sa Procedimiento de conjugacion
US20070253985A1 (en) 2006-04-26 2007-11-01 Wyeth Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
CL2007003209A1 (es) * 2006-11-07 2008-05-09 Acambis Inc Composicion que comprende una vacuna de flavivirus vivos atenuados; composicion que comprende un producto farmaceutico derivado de virus o proteina; un metodo para la elaboracion de una composicion terapeutica que comprende liofilizar las composicion
AU2009221180B2 (en) 2008-03-05 2014-02-13 Sanofi Pasteur Process for stabilizing an adjuvant containing vaccine composition
CN107096020A (zh) * 2009-06-22 2017-08-29 惠氏有限责任公司 金黄色葡萄球菌抗原的免疫原性组合物

Also Published As

Publication number Publication date
IL226793B (en) 2019-02-28
EP3150222A1 (en) 2017-04-05
PT3150222T (pt) 2020-02-03
EP2654784A2 (en) 2013-10-30
ES2769425T3 (es) 2020-06-25
HK1197370A1 (en) 2015-01-16
HUE047263T2 (hu) 2020-04-28
PT2654784T (pt) 2017-02-13
US20130259896A1 (en) 2013-10-03
DK2654784T3 (en) 2017-02-13
MX2013006960A (es) 2013-07-15
DK3150222T3 (da) 2020-01-27
CN103826656B (zh) 2015-08-26
KR101808398B1 (ko) 2017-12-12
HUE033072T2 (hu) 2017-11-28
AU2011346535B2 (en) 2015-09-24
MX350170B (es) 2017-08-28
SI2654784T1 (sl) 2017-01-31
RU2013128277A (ru) 2015-01-27
BR112013016153A2 (pt) 2017-07-11
CA2819120C (en) 2016-07-05
EP3150222B1 (en) 2019-11-27
EP2654784B1 (en) 2016-12-07
CA2819120A1 (en) 2012-06-28
SI3150222T1 (sl) 2020-02-28
PL2654784T3 (pl) 2017-08-31
WO2012085872A3 (en) 2012-08-30
RU2570730C2 (ru) 2015-12-10
JP6097478B2 (ja) 2017-03-15
JP2012136518A (ja) 2012-07-19
KR20150129071A (ko) 2015-11-18
ES2614815T3 (es) 2017-06-02
AU2011346535A1 (en) 2013-06-13
WO2012085872A2 (en) 2012-06-28
KR20130114210A (ko) 2013-10-16
CN103826656A (zh) 2014-05-28

Similar Documents

Publication Publication Date Title
SG10201406520YA (en) Immunogenic compositions of staphylococcus aureus antigens
IL226793B (en) Stable immunogenic compositions of staphylococcus aureus antigens
ZA202002470B (en) Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
IL231104A0 (en) Helper assemblies of antigens for Staphylococcus aureus
EP2549993A4 (en) ANTIMICROBIAL COMPOSITIONS
ZA201403788B (en) Stable pesticidal compositions
ZA201300073B (en) Compositions comprising optical benefit agents
AP2013006769A0 (en) Pesticidal compositions
BR112013017664A2 (pt) composições de pó de cacau
GB201015132D0 (en) Vaccine composition
IL238328A0 (en) Stable preparations that include peracetic acid
PL2768936T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
EP2531026A4 (en) ANTIMICROBIAL FORMULATIONS ON POLYSACCHARID BASE
EP2640418A4 (en) IMMUNOGENIC COMPOSITIONS
EP2605654A4 (en) ANTIMICROBIAL COMPOSITIONS
SI2407155T1 (sl) Preparati na osnovi inekalcitola
ZA201301908B (en) Immunogenic compositions
GB201111128D0 (en) Antimicrobial compositions
GB201002594D0 (en) Antimicrobial compositions
GB201013150D0 (en) Antimicrobial compositions
GB201010944D0 (en) Antimicrobial compositions
GB201003799D0 (en) Antimicrobial compositions
AU2012900227A0 (en) Compositions of nimorazole
GB201005587D0 (en) Novel formulations